Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1
AbstractContext Cholangiocarcinoma with highly heterogeneous, aggressive, and multidrug resistance has a poor prognosis. Although babaodan (BBD) combined with cisplatin improved non-small cell lung cancer efficacy, its impact on overcoming resistance in cholangiocarcinoma remains unexplored.Objectiv...
Main Authors: | Jiong Li, Xiangjun Ma, Faying Xu, Yuanliang Yan, Weiqing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/13880209.2024.2331060 |
Similar Items
-
Lipopolysaccharide induces human pulmonary micro-vascular endothelial apoptosis via the YAP signaling pathway
by: Lei Yi, et al.
Published: (2016-10-01) -
Retracted: microRNA‐497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma
by: Lei Zhang, et al.
Published: (2016-02-01) -
LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP
by: Lin Hu, et al.
Published: (2020-09-01) -
Apelin-13 inhibits hypoxia-induced retinal Müller cell apoptosis by regulating YAP entry into the nucleus
by: Lei Sun, et al.
Published: (2020-06-01) -
Polydatin attenuates tubulointerstitial fibrosis in diabetic kidney disease by inhibiting YAP expression and nuclear translocation
by: Manlin He, et al.
Published: (2022-10-01)